Aton Ra Partners Biomarin Pharmaceutical Inc Transaction History

Aton Ra Partners

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$75.51 - $84.79 $560,963 - $629,904	-7,429 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $112,618 - $136,669	1,507 Added 25.45%	7,429 $561,000
Q4 2020 Feb 19, 2021	BUY	$72.61 - $90.2 $429,996 - $534,164	5,922 New	5,922 $519,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.